Advanced Search >
Keyword: none
Clinical Specialty: Pathology
Search within:  

Sort results by:      



1-20 of 127   Next >
 
3.  
4.  
Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing. 2015 Jul. NGC:010769
Clinical Pharmacogenetics Implementation Consortium - Independent Expert Panel. View all guidelines by the developer(s)
5.  
Diagnosing prostate cancer: PROGENSA PCA3 assay and Prostate Health Index. 2015 Jun 2. NGC:010722
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
6.  
Fluorouracil chemotherapy: the My5-FU assay for guiding dose adjustment. 2014 Dec 10. NGC:010621
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
9.  
Laboratory testing for the diagnosis of HIV infection: updated recommendations. 1989 (revised 2014 Jun 27). NGC:010520
Association of Public Health Laboratories - Professional Association; Centers for Disease Control and Prevention - Federal Government Agency [U.S.]. View all guidelines by the developer(s)
10.  
11.  
12.  
13.  
14.  
Management of lung cancer. A national clinical guideline. 1998 Feb (revised 2014 Feb). NGC:010220
Scottish Intercollegiate Guidelines Network - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
15.  
Pixantrone monotherapy for treating multiply relapsed or refractory aggressive non-Hodgkin's B-cell lymphoma. 2014 Feb. NGC:010286
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
16.  
Sentinel node biopsy in primary cutaneous melanoma. 2011 Feb (revised 2014 Feb). NGC:010344
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
17.  
ACR Appropriateness Criteria® abnormal vaginal bleeding. 1996 (revised 2014). NGC:010459
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
18.  
ACR Appropriateness Criteria® indeterminate renal mass. 1996 (revised 2014). NGC:010456
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
19.  
ACR Appropriateness Criteria® post-treatment surveillance of bladder cancer. 1996 (revised 2014). NGC:010458
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
20.  
ACR Appropriateness Criteria® pre-irradiation evaluation and management of brain metastases. 1999 (revised 2014). NGC:010462
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
1-20 of 127   Next >